NCT06482346View on ClinicalTrials.gov

Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

July 9, 2025

Study Completion Date

July 9, 2025

Conditions
Healthy Adult Male Volunteers
Interventions
BIOLOGICAL

MT-3534

Solution for infusion; Intravenous (IV)

BIOLOGICAL

Placebo

Solution for infusion; Intravenous (IV)

Trial Locations (1)

160-0004

Clinical Research Hospital Tokyo, Shinjuku-ku

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY